跳至主要内容
临床试验/JPRN-UMIN000025765
JPRN-UMIN000025765已完成未知

A pilot study of Susceptibility testing based Fourth-line Helicobacter pylori eradication therapy - Susceptibility based Fourth-line eradication

Yokohama City University Hospital0 个研究点目标入组 30 人开始时间: 2017年1月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • A patient who don't agree for endoscopy and susceptible testing as own expense medical care before eradication therapy. Past history of allergy or side effect requiring treatment for the drugs used in this study. Pregnancy or lactation. A patient with brain and spinal cord disease. A patient with infectious mononucleosis. Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction. Patients who are disqualified for the study by physicians.

研究者

相似试验

A pilot study of Susceptibility testing based... | 临床试验